Objective: Two different Medtronic implantable pulse generator (IPG) models are currently used in clinical applications of deep brain stimulation (DBS): Soletra and Kinetra. The goal of this study was to evaluate and compare the stimulation waveforms produced by each IPG model. Methods: We recorded waveforms from a broad range of stimulation parameter settings in each IPG model, and compared them to idealized waveforms that adhered to the parameters specified in the programming device. We then used a previously published computational model to predict the neural response to the various stimulation waveforms. Results: The stimulation waveforms produced by the IPGs differed from the idealized waveforms assumed in previous theoretical and clinical studies, and the waveforms differed among the IPG models. These differences were greater at higher frequencies and longer pulse widths, and caused variations of up to 0.4 V in activation thresholds for model axons located 3 mm from the DBS electrode contact. Conclusions: The specific details of the stimulation waveform directly affect the neural response to DBS and should be accounted for in theoretical and experimental studies of DBS. Significance: While the clinical selection of DBS parameters is individualized to each patient based on behavioral outcomes, scientific analysis of stimulation parameter settings and clinical threshold measurements are subject to a previously unrecognized source of error unless the actual waveforms produced by the IPG are accounted for.
Introduction
Deep brain stimulation (DBS) is an established therapy for movement disorders, and it shows promise for the treatment of a variety of other neurological conditions. DBS, like other neurostimulation therapies, represents the culmination of decades of basic research on the effects of electrical stimulation on neural tissue. This body of work has demonstrated three important principles: (1) the neural response to stimulation is modulated by the shape of the stimulation waveform, (2) waveforms must be biphasic to prevent tissue damage, and (3) the cathodic (negative) phase of the waveform has the greatest effect on neural activation. These principles are directly relevant for DBS, but the technical details of the stimulation waveforms generated by clinical DBS devices have received little attention.
Clinical programming of DBS is customized to each individual patient, with the goal of optimizing therapeutic benefit. And, it is well recognized that the therapeutic benefit achieved by DBS is primarily dependent on precise electrode placement and careful clinical selection of stimulation parameters (Moro et al., 2006; Rezai et al., 2006; Volkmann et al., 2006) . However, the details of the stimulation waveform become important when defining correlations between DBS parameter settings, clinical outcomes, and/or experimental threshold measurements. 
